Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 2, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revance Therapeutics, Inc.
| 1K |
$2.18 | $2,184.50 | +0.52% | 193.67K |
Jun 30
| |||||||
Revance Therapeutics, Inc.
| -13.18K |
$5.12 | -$67,479.49 | -6.40% | 192.67K |
Mar 15 - Mar 18
| |||||||
Revance Therapeutics, Inc.
| 17.45K |
—
|
—
| +9.26% | 205.85K |
Feb 29
| |||||||
Revance Therapeutics, Inc.
| 96.67K |
—
|
—
| +105.38% | 188.4K |
Jan 31
| |||||||
Revance Therapeutics, Inc.
| 434 |
$7.47 | $3,241.98 | +0.48% | 91.73K |
Dec 31
| |||||||
Revance Therapeutics, Inc.
| 11.4K |
$18.91 | -$212,075.65 | +14.27% | 91.3K |
Aug 11
| |||||||
Revance Therapeutics, Inc.
| -932.00 |
$20.33 | -$30,592.03 | -1.15% | 79.9K |
Jun 30 - Jul 3
| |||||||
Revance Therapeutics, Inc.
| -3.20K |
$30.64 | -$98,069.57 | -3.81% | 80.83K |
Jun 1 - Jun 2
| |||||||
Revance Therapeutics, Inc.
| 20.95K |
$34.55 | -$739,338.21 | +33.21% | 84.03K |
Feb 2 - May 15
| |||||||
Revance Therapeutics, Inc.
| -3.20K |
$31.70 | -$101,471.70 | -4.83% | 63.08K |
May 1
| |||||||
Revance Therapeutics, Inc.
| -3.20K |
$32.15 | -$102,912.15 | -4.61% | 66.28K |
Apr 3
| |||||||
Revance Therapeutics, Inc.
| -3.74K |
$30.65 | -$114,600.35 | -5.11% | 69.48K |
Mar 15
| |||||||
Revance Therapeutics, Inc.
| 23.83K |
$31.59 | -$584,883.52 | +48.25% | 73.22K |
Sep 22 - Mar 9
| |||||||
Revance Therapeutics, Inc.
| -3.20K |
$33.50 | -$107,233.50 | -6.09% | 49.39K |
Mar 1
|
Scheduled
| ||||||
Revance Therapeutics, Inc.
| -2.08K |
$33.21 | -$69,242.85 | -3.81% | 52.59K |
Feb 15
| |||||||
Revance Therapeutics, Inc.
| -3.20K |
$34.60 | -$110,754.60 | -5.53% | 54.68K |
Jan 31 - Feb 1
|
Scheduled
| ||||||
Revance Therapeutics, Inc.
| -1.00K |
$31.00 | -$31,000.00 | -1.70% | 57.88K |
Jan 20
|
Scheduled
| ||||||
Revance Therapeutics, Inc.
| -3.70K |
$27.16 | -$100,525.00 | -5.91% | 58.88K |
Jan 9
|
Scheduled
| ||||||
Revance Therapeutics, Inc.
| 645 |
$12.18 | $7,856.42 | +1.04% | 62.58K |
Dec 31
| |||||||
Revance Therapeutics, Inc.
| -1.56K |
$21.50 | -$33,475.50 | -2.45% | 61.93K |
Dec 15
| |||||||
Revance Therapeutics, Inc.
| 965 |
$11.75 | $11,335.86 | +1.54% | 63.49K |
Jun 30
| |||||||
Revance Therapeutics, Inc.
| -2.61K |
$15.79 | -$41,164.53 | -4.00% | 62.52K |
Mar 15
| |||||||
Revance Therapeutics, Inc.
| -2.92K |
$13.35 | -$39,035.40 | -4.30% | 65.13K |
Feb 15
| |||||||
Revance Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 2
| |||||||
Revance Therapeutics, Inc.
| 404 |
$13.87 | $5,604.29 | +0.60% | 68.06K |
Dec 31
| |||||||
Revance Therapeutics, Inc.
| -1.56K |
$15.92 | -$24,771.52 | -2.25% | 67.65K |
Dec 15
| |||||||
Revance Therapeutics, Inc.
| 446 |
$24.09 | $10,743.69 | +0.65% | 69.21K |
Jun 30
| |||||||
Revance Therapeutics, Inc.
| -2.66K |
$28.97 | -$76,973.29 | -3.72% | 68.76K |
Feb 15
| |||||||
Revance Therapeutics, Inc.
| 22.62K |
—
|
—
| +46.35% | 71.42K |
Feb 2
| |||||||
Revance Therapeutics, Inc.
| 493 |
$21.36 | $10,530.73 | +1.02% | 48.8K |
Dec 31
| |||||||
Revance Therapeutics, Inc.
| -1.56K |
$26.75 | -$41,623.00 | -3.12% | 48.31K |
Dec 15
| |||||||
Revance Therapeutics, Inc.
| 10.3K |
$25.14 | -$136,912.44 | +26.05% | 49.86K |
Sep 30
| |||||||
Revance Therapeutics, Inc.
| 763 |
$13.80 | $10,525.97 | +1.97% | 39.56K |
Jun 30
| |||||||
Revance Therapeutics, Inc.
| -576.00 |
$25.33 | -$14,590.08 | -1.46% | 38.8K |
Feb 15
| |||||||
Revance Therapeutics, Inc.
| 16.5K |
—
|
—
| +72.14% | 39.37K |
Jan 23
| |||||||
Revance Therapeutics, Inc.
| 504 |
$10.82 | $5,453.28 | +2.25% | 22.87K |
Dec 31
| |||||||
Revance Therapeutics, Inc.
| -1.56K |
$15.99 | -$24,880.44 | -6.50% | 22.37K |
Dec 15
| |||||||
Revance Therapeutics, Inc.
| 923 |
$11.02 | $10,175.61 | +4.01% | 23.92K |
Jun 28
| |||||||
Revance Therapeutics, Inc.
| 5K |
—
|
—
| +27.78% | 23K |
Jan 24
| |||||||
Revance Therapeutics, Inc.
| 18K |
—
|
—
|
∞
| 18K |
Nov 5
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.